Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Romana Pulci"'
Autor:
Arturo Galvani, Paola Magnaghi, Enrico Pesenti, Antonella Isacchi, Daniele Donati, Eduard Felder, Gang Li, Jean-Michel Vernier, Jason Harris, Ge Wei, David Anderson, Luca Mologni, Tiziano Bandiera, Paolo Orsini, Daniele Casero, Maria Beatrice Saccardo, Nadia Amboldi, Nilla Avanzi, Anna Degrassi, Gemma Texido, Marina Ciomei, Dario Ballinari, Romana Pulci, Cristina De Ponti, Roberta Bosotti, Patrizia Banfi, Maria Menichincheri, Elena Ardini
Supplementary experimental procedures are described
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e7349af36e6ac21496c6964180ab8f
https://doi.org/10.1158/1535-7163.22508037
https://doi.org/10.1158/1535-7163.22508037
Autor:
Arturo Galvani, Paola Magnaghi, Enrico Pesenti, Antonella Isacchi, Daniele Donati, Eduard Felder, Gang Li, Jean-Michel Vernier, Jason Harris, Ge Wei, David Anderson, Luca Mologni, Tiziano Bandiera, Paolo Orsini, Daniele Casero, Maria Beatrice Saccardo, Nadia Amboldi, Nilla Avanzi, Anna Degrassi, Gemma Texido, Marina Ciomei, Dario Ballinari, Romana Pulci, Cristina De Ponti, Roberta Bosotti, Patrizia Banfi, Maria Menichincheri, Elena Ardini
Supplementary Figure 1. Efficacy of entrectinib on KM12 xenograft model using the scheduling 4 days on/ 3 days off. Supplementary Figure 2. Mechanism of action of entrectinib compared to crizotinib in ALK-dependent Ba/F3 cells. Supplementary Figure 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f11ccf8c2eee09b004c4cb5d12e7089
https://doi.org/10.1158/1535-7163.22508040
https://doi.org/10.1158/1535-7163.22508040
Autor:
Arturo Galvani, Roberto Cairoli, Matteo G. Della Porta, Alessandro Di Sanzo, Cristina Davite, Roberta Bosotti, Erika Ravelli, Francesco Fiorentini, Lucia Zanetta, Elena Colajori, Elena Ardini, Antonella Isacchi, Marina Ciomei, Frank Xiaodong Gan, Federico Lussana, Rosalinda Gatto, Giuseppe Rossi, Romana Pulci, Andrea Lombardi Borgia, Alessandro Rambaldi
Publikováno v:
Blood. 134:3855-3855
Background: NMS-03592088 is a novel, potent inhibitor of the FLT3, CSF1R and KIT receptor tyrosine kinases (KD < 1 nM for all three targets). The compound demonstrated high preclinical efficacy following oral administration in all tested target-depen
Autor:
Jason Harris, Anna Degrassi, Gang Li, Tiziano Bandiera, Arturo Galvani, Ge Wei, David F. Anderson, Marina Ciomei, Cristina De Ponti, Eduard R. Felder, Patrizia Banfi, Daniele Casero, Antonella Isacchi, Jean-Michel Vernier, Daniele Donati, Maria Menichincheri, Paolo Orsini, Gemma Texido, Maria Beatrice Saccardo, Nilla Avanzi, Enrico Pesenti, Dario Ballinari, Nadia Amboldi, Luca Mologni, Paola Magnaghi, Elena Ardini, Romana Pulci, Roberta Bosotti
Publikováno v:
Molecular cancer therapeutics. 15(4)
Activated ALK and ROS1 tyrosine kinases, resulting from chromosomal rearrangements, occur in a subset of non–small cell lung cancers (NSCLC) as well as other tumor types and their oncogenic relevance as actionable targets has been demonstrated by t
Autor:
Marco Brughera, Guy Mazue, Donatella Moneta, Paolo Carminati, Romana Pulci, Giovanna Scampini, Philippe Dostert, Silvana Castellino
Publikováno v:
Alternatives to Laboratory Animals. 21:38-42
The aim of this study was to verify an in vitro model of hepatotoxicity, designed to assess the production of reactive species from biologically-inert chemicals through their metabolic transformation. One example is allyl alcohol, which produces acro
Publikováno v:
Toxicology Letters. 180:S151-S152